Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Foresee Pharmaceuticals Co., Ltd. (6576) Income Statement

Foresee Pharmaceuticals Co., Ltd. Income Statement

Last quarter (Q2 2026), Foresee Pharmaceuticals Co., Ltd.'s total revenue was NT$181.65M, an increase of 62.70% from the same quarter last year. In Q2, Foresee Pharmaceuticals Co., Ltd.'s net income was NT$-123.78M. See Foresee Pharmaceuticals Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 431.27MNT$ 418.69MNT$ 195.04MNT$ 301.51MNT$ 226.03M
NT$ 294.22MNT$ 239.80MNT$ 113.97MNT$ 275.97MNT$ 175.08M
NT$ 1.16BNT$ 1.32BNT$ 1.12BNT$ 745.41MNT$ 713.71M
Depreciation and AmortizationNT$ 68.13MNT$ 80.52MNT$ 73.63MNT$ 51.15MNT$ 51.48M
NT$ -784.50MNT$ -945.98MNT$ -912.16MNT$ -386.58MNT$ -475.83M
NT$ -862.32MNT$ -1.08BNT$ -1.01BNT$ -437.73MNT$ -527.31M
NT$ 4.11MNT$ 46.59MNT$ 18.99MNT$ 31.31MNT$ 10.64M
NT$ -858.20MNT$ -1.03BNT$ -988.63MNT$ -438.13MNT$ -527.99M
NT$ -883.15MNT$ -1.08BNT$ -1.04BNT$ -472.64MNT$ -569.27M
Per Share Metrics
Basic EPSNT$ -5.70NT$ -7.87NT$ -8.14NT$ -4.00NT$ -4.80
Diluted EPSNT$ -5.70NT$ -7.87NT$ -8.14NT$ -4.00NT$ -4.80
Weighted Average Shares Outstanding154.94M137.32M127.28M118.04M118.68M
Weighted Average Shares Outstanding (Diluted)154.94M137.32M127.28M118.04M118.68M

Currency in TWD

Foresee Pharmaceuticals Co., Ltd. Earnings and Revenue History

-1.2B-600M0600M-750 %-500 %-250 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin